Negligible serum anti-müllerian hormone: pregnancy and birth after a 1-month course of an oral contraceptive, ovarian hyperstimulation, and intracytoplasmic sperm injection
Authors:
- Susanna FerreroSFSusanna Ferrero
- Marcello IacobelliMIMarcello Iacobelli
- Ermanno GrecoEGErmanno Greco
- 1 July 2009
- journal article
- case report
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (1) , 395.e9-395.e12
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormoneFertility and Sterility, 2009
- The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle countFertility and Sterility, 2009
- Ovarian hyperstimulation after a short course of an oral contraceptive in a patient with premature ovarian failureFertility and Sterility, 2008
- Significance of metaphase II human oocyte morphology on ICSI outcomeFertility and Sterility, 2008
- Ovarian ReserveAnnals of the New York Academy of Sciences, 2008
- Undetectable serum anti-Müllerian hormone levels and occurrence of ongoing pregnancyFertility and Sterility, 2008
- Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injectionFertility and Sterility, 2007
- Absence of follicular phase defect in women with recurrent miscarriageFertility and Sterility, 2006
- Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced MenopauseJournal of the Society for Gynecologic Investigation, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004